The effect of COVID-19 on Renal and Immuno-Suppressed Patients (C19-RISP)

C19-RISP aims to :

  1. Study the effect of COVID-19 in patients with renal disease (including dialysis patients) and immunosuppressed patients (including transplant recipients and patients with autoimmune disease);
  2. Investigate the immune response and pattern of inflammatory markers in these patient groups and compare them with healthy controls;
  3. Describe the clinical course and outcome of COVID-19 infection in patients with renal disease and immunosuppressed patients.
Imperial PI Dr Michelle Willicombe
Trial Sponsor Imperial College London
Study type Observational
Study status In recruitment